Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-24

Clinical Trial Update: Moisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early Childhood [Phase 3]

View source ↗

Summary

Phase 3 trial update investigating a moisturizer to prevent symptoms of atopic dermatitis in early childhood.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Infectopharm Arzneimittel GmbH | Conditions: Atopic Dermatitis, Infant, Newborn | Phase 3 | Status: UNKNOWN